1.Construction of nomogram prediction model for knee joint cartilage injury in patients with anterior cruciate ligament rupture
Jianfeng NI ; Heyuan MENG ; Bao ZHANG ; Jixiang ZHENG
Chinese Journal of Postgraduates of Medicine 2024;47(5):427-433
Objective:To analyze the relevant factors of knee joint cartilage injury in patients with anterior cruciate ligament rupture and construct a nomogram prediction model.Methods:The clinical data of 160 patients with unilateral anterior cruciate ligament rupture who underwent surgical treatment from March 2020 to February 2023 at Tianjin 272 Hospital and the Ninety-Eighty-Third Hospital of the People′s Liberation Army Joint Logistics Support Force were retrospectively analyzed. The patients were divided into injured group (97 cases) and non injured group (63 cases) based on whether there was concurrent knee joint cartilage injury. The optimal cutoff values of each factor were analyzed by the receiver operating characteristic (ROC) curve. Using a multiple Logistic regression model to analyze the independent risk factors of knee joint cartilage injury in patients with anterior cruciate ligament rupture; construct a nomogram model for predicting knee joint cartilage injury in patients with anterior cruciate ligament rupture. The internal validation of the nomogram model was validated using calibration curves, and the predictive performance of the nomogram model is evaluated using decision curves.Results:The body mass index (BMI), rate of meniscus injury, number of sprains and injury time in injured group were significantly higher than those in non injured group: (24.15 ± 2.52) kg/m 2 vs. (22.84 ± 3.13) kg/m 2, 77.32% (75/97) vs. 17.46% (11/63), (2.64 ± 0.90) times vs. (1.17 ± 0.64) times, (19.15 ± 3.77) d vs. (12.92 ± 3.14) d, and there were statistical differences ( P<0.05). The ROC curve analysis results show that the optimal cutoff values for BMI, number of sprains and injury time were 22.9 kg/m 2, once and 16 d, respectively. BMI (>22.9 kg/m 2), meniscus injury (with), number of sprains (>1 time) and injury time (>16 d) were independent risk factors for knee joint cartilage injury in patients with anterior cruciate ligament rupture, and they were also predictive factors for building nomogram model. The internal validation results show that the nomogram model predicts a C-index of 0.819 (95% CI 0.715 to 0.883) for patients with anterior cruciate ligament rupture complicated by knee cartilage injury. The consistency between the observed values and the predicted values was good. The nomogram model predicts a threshold of over 0.14 for knee joint cartilage injury in patients with anterior cruciate ligament rupture, and the clinical net benefits provided by the column chart model were higher than BMI, meniscus injury, number of sprains and injury time. Conclusions:This study constructs a nomogram model based on BMI, meniscus injury, number of sprains, and injury time to predict knee joint cartilage injury in patients with anterior cruciate ligament rupture. The model has good predictive value for knee joint cartilage injury in patients with anterior cruciate ligament rupture, and can be used to identify high-risk patients who are prone to knee joint cartilage injury in patients with anterior cruciate ligament rupture.
2.Effects of Snail gene modification on CXCR4 expression of human bone mesenchymal stem cells and their capacity of migration to SDF-1 in vitro.
Jixiang NI ; Xianzhe LIU ; Yunhong ZHA ; Yuanwu MEI
Chinese Journal of Biotechnology 2009;25(2):242-250
In order to investigate the transfer and expression of Snail gene in human bone mesenchymal stem cells (MSCs) and to study effects of Snail gene modification on the CXCR4 expression of human MSCs and their capacity of migration to SDF-1 in vitro, the plasmid PCAGGSneo-Snail-HA or the control vector of PCAGGSneo was transferred into the cells. Fluorescence activated cell sorting analysis, immunofluorescence staining and RT-PCR were used to study the expression of CXCR4 by MSCs. Chemotaxis assays were performed to evaluate the migratory capacity of MSCs-Sna and MSCs-neo to SDF-1 in vitro. For the blocking assay, CXCR4 blocking antibody was added into cell culture. CXCR4 expression was higher in MSCs-Sna than that in MSCs-neo (P < 0.05). Chemotaxis assays showed that SDF-1alpha stimulated migratory activity of MSCs-Sna more than MSCs-neo in vitro (P < 0.05). Moreover, the SDF-1alpha-induced migratory activity of MSCs-Sna was inhibited in a concentration-dependent manner by a CXCR4-blocking antibody. It was concluded that Snail enhanced expression of CXCR4 in MSCs, providing a plausible mechanism for Snail-mediated MSCs transmigration to damaged tissues in vivo where SDF-1 has been shown to be up-regulated as part of injury responses.
Bone Marrow Cells
;
cytology
;
Cell Movement
;
genetics
;
Cells, Cultured
;
Chemokine CXCL12
;
metabolism
;
Humans
;
Mesenchymal Stromal Cells
;
cytology
;
metabolism
;
Receptors, CXCR4
;
genetics
;
metabolism
;
Snail Family Transcription Factors
;
Transcription Factors
;
genetics
;
Transduction, Genetic
3.Expression and role of Hippo signaling pathway in non-small cell lung cancer
Zhao WANG ; Yingnan WANG ; Jixiang NI ; Jing ZHU
Journal of International Oncology 2019;46(4):239-242
Hippo signaling pathway plays an important role in the growth and regeneration of animal organs. Studies have shown that the misexpression of Hippo signaling pathway composed of yes-associated protein and trascriptional co-activator with PDZ-binding motif is involved in the development of non-small cell lung cancer(NSCLC)and has synergistic effect with mutant p53. In addition,its overexpression leads to drug resistance in lung cancer treatment and inhibition of its expression may benefit cancer patients. The expression and role of Hippo signaling pathway in NSCLC are described in detail,which is expected to provide a new direction for targeted therapy of lung cancer.
4.Research progress of cryoablation in the treatment of lung cancer
Yuankun MA ; Jixiang NI ; Tianming ZHAO ; Xuehua HU ; Yuting YANG
Journal of International Oncology 2019;46(7):427-429
Clinical studies have confirmed that cryoablation is a safe and effective treatment for lung cancer. Cryoablation has been clinically used in the treatment of various types of lung cancer,and has achieved good therapeutic effects. Some of the complications of cryoablation can be alleviated after symptomatic treat-ment. However,cryoablation still needs further research and exploration in clinical applications.